AstraZeneca PLC is 148.8x more valuable than Bausch Health Companies Inc. by market capitalization ($286.27 B vs $1.92 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | BHC | AZN |
|---|---|---|
| Market cap | $1.92 B | $286.27 B |
| US-listed rank | #2124 | #45 |
| Revenue (latest FY) | $10.27B | - |
| Net income (latest FY) | $157.00M | - |
| Net margin | 1.5% | - |
| P/E (trailing FY) | 12.3 | - |
| SEC filings | 2,398 | 1,004 |
AstraZeneca PLC is 148.8x more valuable than Bausch Health Companies Inc. by market capitalization ($286.27 B vs $1.92 B).
Full pages: Bausch Health Companies Inc. and AstraZeneca PLC, or browse the full rankings.